238 related articles for article (PubMed ID: 15106045)
1. [Outcome of 268 patients with pancreatic carcinoma treated surgically].
Uravic M; Depolo A; Dobrilla-Dintinjana R; Petrosic N; Grbas H; Miletic D; Tomse Z; Kastelan Z
Zentralbl Chir; 2004 Apr; 129(2):125-9. PubMed ID: 15106045
[TBL] [Abstract][Full Text] [Related]
2. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
Ridwelski K; Meyer F; Schmidt U; Lippert H
Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
[TBL] [Abstract][Full Text] [Related]
3. The role of paraaortic lymph node involvement on early recurrence and survival after macroscopic curative resection with extended lymphadenectomy for pancreatic carcinoma.
Shimada K; Sakamoto Y; Sano T; Kosuge T
J Am Coll Surg; 2006 Sep; 203(3):345-52. PubMed ID: 16931307
[TBL] [Abstract][Full Text] [Related]
4. Extended lymphadenectomy in cephalic pancreatoduodenectomy. Personal observations.
Meriggi F; Gramigna P; Forni E
Hepatogastroenterology; 2007 Mar; 54(74):549-55. PubMed ID: 17523320
[TBL] [Abstract][Full Text] [Related]
5. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma.
Wagner M; Redaelli C; Lietz M; Seiler CA; Friess H; Büchler MW
Br J Surg; 2004 May; 91(5):586-94. PubMed ID: 15122610
[TBL] [Abstract][Full Text] [Related]
6. Unresectable pancreatic carcinoma: correlating length of survival with choice of palliative bypass.
Di Fronzo LA; Cymerman J; Egrari S; O'Connell TX
Am Surg; 1999 Oct; 65(10):955-8. PubMed ID: 10515542
[TBL] [Abstract][Full Text] [Related]
7. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer.
Pawlik TM; Gleisner AL; Cameron JL; Winter JM; Assumpcao L; Lillemoe KD; Wolfgang C; Hruban RH; Schulick RD; Yeo CJ; Choti MA
Surgery; 2007 May; 141(5):610-8. PubMed ID: 17462460
[TBL] [Abstract][Full Text] [Related]
8. Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients.
Kuhlmann KF; de Castro SM; Wesseling JG; ten Kate FJ; Offerhaus GJ; Busch OR; van Gulik TM; Obertop H; Gouma DJ
Eur J Cancer; 2004 Mar; 40(4):549-58. PubMed ID: 14962722
[TBL] [Abstract][Full Text] [Related]
9. Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma.
O'Connor JK; Sause WT; Hazard LJ; Belnap LP; Noyes RD
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1060-6. PubMed ID: 15978737
[TBL] [Abstract][Full Text] [Related]
10. Carcinoma of the pancreas--bypass versus resection?
Ong CL; Rauff A
J R Coll Surg Edinb; 1993 Jun; 38(3):149-51. PubMed ID: 7687675
[TBL] [Abstract][Full Text] [Related]
11. En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients.
Yekebas EF; Bogoevski D; Cataldegirmen G; Kunze C; Marx A; Vashist YK; Schurr PG; Liebl L; Thieltges S; Gawad KA; Schneider C; Izbicki JR
Ann Surg; 2008 Feb; 247(2):300-9. PubMed ID: 18216537
[TBL] [Abstract][Full Text] [Related]
12. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?
Schnelldorfer T; Ware AL; Sarr MG; Smyrk TC; Zhang L; Qin R; Gullerud RE; Donohue JH; Nagorney DM; Farnell MB
Ann Surg; 2008 Mar; 247(3):456-62. PubMed ID: 18376190
[TBL] [Abstract][Full Text] [Related]
13. [Palliative surgery in nonresectable pancreatic carcinoma].
Guglielminetti D; Burgini M; Gaddoni G; Polacchini G; Fiorentini G
G Chir; 1994 Oct; 15(10):439-42. PubMed ID: 7531479
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing survival after bypass procedures in patients with advanced pancreatic adenocarcinomas.
Müller MW; Friess H; Köninger J; Martin D; Wente MN; Hinz U; Ceyhan GO; Blaha P; Kleeff J; Büchler MW
Am J Surg; 2008 Feb; 195(2):221-8. PubMed ID: 18154768
[TBL] [Abstract][Full Text] [Related]
15. Curative and palliative surgical treatment of pancreaticoduodenal adenocarcinoma.
Hoitsma HF; Meijer S; den Otter G
Arch Chir Neerl; 1978; 30(3):151-61. PubMed ID: 81663
[TBL] [Abstract][Full Text] [Related]
16. Adenosquamous carcinoma of the pancreas: a single-institution experience comparing resection and palliative care.
Smoot RL; Zhang L; Sebo TJ; Que FG
J Am Coll Surg; 2008 Sep; 207(3):368-70. PubMed ID: 18722942
[TBL] [Abstract][Full Text] [Related]
17. Improving survival following surgery for pancreatic ductal adenocarcinoma--a ten-year experience.
Hoem D; Viste A
Eur J Surg Oncol; 2012 Mar; 38(3):245-51. PubMed ID: 22217907
[TBL] [Abstract][Full Text] [Related]
18. Is resection of periampullary or pancreatic adenocarcinoma with synchronous hepatic metastasis justified?
Gleisner AL; Assumpcao L; Cameron JL; Wolfgang CL; Choti MA; Herman JM; Schulick RD; Pawlik TM
Cancer; 2007 Dec; 110(11):2484-92. PubMed ID: 17941009
[TBL] [Abstract][Full Text] [Related]
19. Outcome of pancreaticoduodenectomy with extended retroperitoneal lymphadenectomy for adenocarcinoma of the head of the pancreas.
Yang YM; Wan YL; Tian XD; Zhuang Y; Huang YT
Chin Med J (Engl); 2005 Nov; 118(22):1863-9. PubMed ID: 16313840
[TBL] [Abstract][Full Text] [Related]
20. [Oncologic risk in pylorus preservation in resection of ductal pancreas carcinoma].
Gerdes B; Ramaswamy A; Bartsch D; Rothmund M
Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():1087-9. PubMed ID: 9574341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]